Similar articles

• Bias in treatment assignment in controlled clinical trials.

  [No authors listed] [No authors listed] N Engl J Med. 1984 Jun 14;310(24):1610-2. doi: 10.1056/nejm198406143102419. N Engl J Med. 1984. PMID: 6727931 No abstract available.
• Double-blind assessment of therapeutic efficacy in clinical trials.

  Cohen S. Cohen S. Dig Dis Sci. 1983 Jun;28(6):564-5. doi: 10.1007/BF01308160. Dig Dis Sci. 1983. PMID: 6861586 No abstract available.
• Without double blind randomization, what can we conclude?

  Elashoff JD. Elashoff JD. Dig Dis Sci. 1980 Dec;25(12):972-3. doi: 10.1007/BF01308051. Dig Dis Sci. 1980. PMID: 6893816 No abstract available.
• Epidemiologic analyses of causation: the unlearned scientific lessons of randomized trials.

  Feinstein AR. Feinstein AR. J Clin Epidemiol. 1989;42(6):481-9; discussion 499-502. doi: 10.1016/0895-4356(89)90142-x. J Clin Epidemiol. 1989. PMID: 2661727 Review. No abstract available.
• [Instructions and methods for clinical trials of medicinal products for the treatment of chronic systolic heart failure].

  Wink K. Wink K. Arzneimittelforschung. 2008;58(9):475-9. doi: 10.1055/s-0031-1296542. Arzneimittelforschung. 2008. PMID: 18972879 Review. German.